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TransportDiseases like obesity, diabetes or generalized lipodystrophy cause a chronic elevation of circulating fatty
acids that can become cytotoxic, a condition known as lipotoxicity. Fatty acids cause oxidative stress and
alterations in mitochondrial structure and function. The uncoupling of the oxidative phosphorylation is one
of the most recognized deleterious fatty acid effects and several metabolite transporters are known to
mediate in their action. The fatty acid interaction with the carriers leads to membrane depolarization and/or
the conversion of the carrier into a pore. The result is the opening of the permeability transition pore and the
initiation of apoptosis. Unlike the other members of the mitochondrial carrier superfamily, the eutherian
uncoupling protein UCP1 has evolved to achieve its heat-generating capacity in the physiological context
provided by the brown adipocyte and therefore it is activated by the low fatty acid concentrations generated
by the noradrenaline-stimulated lipolysis.drial membrane; OMM, outer
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Long-chain non-esteriﬁed fatty acids (FA), also referred to as free
fatty acids, are an important energy source for most body tissues,
particularly during periods of starvation or prolonged endurance
exercise. Under physiological conditions, FA are not really “free” since
they are avidly bound by proteins like albumin in the circulation or fatty
acid binding proteins within cells. FA are more than substrates for
oxidative metabolism and thus they play a signiﬁcant role in cell sig-
nalling, inﬂuence enzymatic activities, gene expression, ion homeosta-
sis, etc. While ﬂuctuations in the concentration of circulating FA are
important for the physiological regulation of a number of processes,
sustained high FA levels are deleterious [1,2]. Thus, diseases like obesity,
diabetes or generalized lipodystrophy cause a chronic elevation of
circulating FA that can result in cytotoxic intracellular levels. This
condition, termed “lipotoxicity”, can lead to the apoptotic death of the
cell which is then called “lipoapoptosis”[2]. The lipotoxic action is
dependent on the chain length and saturation of the FA molecule.
Unsaturated FA are less toxic than their saturated counterparts and can
even attenuate the toxicity of the latter [3,4].The investigation of the molecular mechanisms behind the FA-
induced lipotoxicity has mainly analyzed the mitochondrial effects.
However, itmustbeborne inmind that FAcan also affect other sites and,
for example, they cause endoplasmic reticulumstress [5] or increase the
production of superoxide by the NADPH oxidase [6] (Fig. 1). The
mitochondrial effects are of special relevance because this organelle
plays a key role in the initiation of apoptosis. The intermembrane space
conﬁnes a number of proapoptotic factors (AIF, smac-DIABLO or
cytochrome c, etc.) that, when released, initiate a caspase-dependent
cell death cascade [7]. The release can be induced either by a direct
permeabilization of the outer mitochondrial membrane (OMM) or by a
change in the permeability properties of the innermitochondrial mem-
brane (IMM). The apoptosis-related alteration of the permeability
properties of the IMM has been termed “permeability transition” and is
due to the opening of a pore, the permeability transitionpore (PTP), that
allows the permeation of solutes of up to 1500 Da. Opening of this pore
causes the collapse of membrane potential, matrix swelling and culmi-
nates with the rupture of the OMM [7,8]. The PTP is a complex whose
composition is dynamically regulated by a variety of stimuli and con-
ditions. It includes cytosolic proteins and proteins from the OMM and
IMM. The most prominent components are the voltage-dependent
anion channel, hexokinase, creatine kinase, cyclophilin D and probably
the phosphate carrier (PIC), the adenine nucleotide translocator (ANT)
or other members of the mitochondrial transporter superfamily [9].
The presence of cyclophilin D confers the PTP its characteristic sen-
sitivity to the inhibition by cyclosporin A. The permeabilization of the
OMMcan occur after the insertion and oligomerization of pro-apoptotic
Bcl-2 family members (Bax, Bak, tBid) or the formation of ceramide
Fig. 1. Lipotoxic effects of fatty acids. FA affect the cell viability by altering mitochondrial function and generating oxidative stress. The oxidation of FA in mitochondria, peroxisomes
(β-oxidation) and endoplasmic reticulum (ω-oxidation) generate ROS. FA also increase ROS production by the NADPH oxidase and give rise to endoplasmic reticulum stress. FA can
cause the release of apoptogenic factors frommitochondria either by inducing the permeabilization of the OMM or by triggering the opening of the PTP. All these actions result in the
initiation of the apoptotic cascade. “MC” represents any member of the mitochondrial carrier family. See text for further details.
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allow the release of the apoptogenic factors [7,10].
The FA effects on mitochondria can be divided in three classes that
are interrelated: (1) increase in the production of reactive oxygen species
(ROS), (2) increase in mitochondrial proton conductance (uncoupling)
and (3) opening of the PTP (Fig. 1). Thus, FA oxidation can cause an
elevation of ROS and trigger PTP opening [6,11]. Additionally, FA can
provoke the permeabilization of the OMM in two ways. Firstly, because
saturated FA are precursors for de novo synthesis of ceramides and,
secondly, because they up-regulate the expression of the pro-apoptotic
Bax togetherwith thedown-regulation of the anti-apoptotic Bcl-2 [12,13].
Nevertheless, the uncoupling of the mitochondrial oxidative phosphor-
ylation is one of the most recognized deleterious FA effects. The un-
coupling phenomenonwasﬁrst described by Pressman and Lardy in 1952
when they reported that FA could stimulate respiration in the absence of
a phosphate acceptor and could also increase the ATPase activity [14,15].
For a long time it was assumed that FA would exert a conventional
protonophoric action on the mitochondrial membranes, i.e. acting like
classical uncouplers [16]. The uncoupling activity was explained with a
cycle that required the transbilayer movement (ﬂip-ﬂop) of the
protonated FA from the cytosolic to the matrix face of the inner mem-
brane and the subsequent return of the anionic form to the cytosolic side.
This cycle would result in the net delivery of protons to the matrix side.
While the ﬂip-ﬂop of the protonated form is extremely fast, the move-
ment of the anion is too slow and thus themechanism of uncouplingwas
not satisfactory. In 1988, Skulachev and coworkers [17,18] showed that
carboxyatractylate, an inhibitor of the ANT, could partially inhibit theuncoupling effect of palmitate in liver mitochondria and proposed that
the ANT was facilitating the translocation of the FA anion and thus pro-
viding the missing arm to the protonophoric cycle. Since then, several
other mitochondrial carriers have been shown to mediate in the un-
coupling effect of FA [3,19–21].2. The mitochondrial carrier protein superfamily and the
uncoupling protein family
The metabolite transporters of the IMM form a protein superfamily
whose most distinctive feature is the internally repetitive structure
where a sequence unit of 100 amino acids is repeated three times [22].
Each repeat contains two transmembrane segments linked by a long
hydrophilic loop. These three loops are oriented toward thematrix side
of the inner membrane, and include the conserved sequence motif
that is currently used to identify potential members of the superfamily
(NCBI conserved domain Pfam00153, mito_carr superfamily). The
elucidation of the three-dimensional structure of theANThas conﬁrmed
this structural arrangement [23]. Therefore, it appears that the super-
family evolvedby triplication of a primordial protein that contained two
transmembrane domains [24,25]. Moreover, since mitochondrial
carriers do not appear to have orthologs in prokaryotes, it has been
proposed that the ancestral mitochondrial carrier may have been an
evolutionary innovation of the ancestral organism, which succeeded to
host the bacterial endosymbiont that eventually became a mitochon-
drion [25,26]. The subsequent diversiﬁcation generated the carrier
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integration of the mitochondrion in the cellular metabolism.
The uncoupling proteins (UCPs) are members of the superfamily
whose biological function should, in principle, be to allow a regulated
discharge of the proton gradient [27,28]. Therefore a UCP would dis-
sipate energy although the actual molecular mechanism could vary
among the different family members. In mammals ﬁve genes encode
proteins considered UCPs [27,29]. UCP1 is present in brown adipose
tissue (BAT), UCP2 is ubiquitous while UCP3 is expressed in skeletal
muscle, heart and BAT. UCP4 and BMCP1 (UCP5) are predominantly
expressed in the nervous system and are only distantly related to the
rest of the family. Genes homologous to themammalianUCPs havebeen
described not only in most phyla of the animal kingdom but also in
plants and unicellular eukaryotes [27,29]. It must be stressed, however,
that the transport activity of most members of the UCP family has been
inferred from their homology to UCP1 and that reports on their un-
coupling activity are either lacking or controversial.
The function of the differentmembers of the UCP protein family is not
fully establishedbut available data point to a general role in theprotection
against oxidative stress. Although the acceleration of respiration due to
UCP-mediated uncouplingwould lead to a reduction in themitochondrial
production of superoxide, it has also been proposed that UCPs induce a
metabolic shift that promotes glycolysis and therefore indirectly lowers
ROS production [30]. Nevertheless, there aremany exampleswhere UCPs
are upregulated in physiological situationswhere there is oxidative stress
and data showing that their overexpression reduces ROS damage. Thus,
UCP2 is induced by agents that cause oxidative stress like lipopolysac-
charide [31], TNFα [32,33] or fatty acids [34], or pathological conditions
involving high ROS levels like liver injury [35], obesity [36], cancer [37] or
diabetes [38–40]. Similarly, transgenic plants with increased UCP levels
show higher tolerance to oxidative stress and UCP genes are upregulated
when plants are exposed to oxidative stress generating agents [41]. All
these observations have led to the consideration of the UCPs as part of the
antioxidant defence system.
The eutherianUCP1 is, however, a proteinwith a distinct physiological
function: heat generation in BAT, a tissue only found in eutherian mam-
mals. This energydissipatorymechanism is usedbymammals tomaintain
their body temperature when cold exposed or to burn excess calories
ingested with the diet. Additionally, eutherian UCP1 present two distinct
biochemical properties: a high nucleotide-sensitive basal proton conduc-
tance and, as it will be later discussed, a high afﬁnity for fatty acids
(physiological activators) [42,43]. Recent phylogenetic analysis based on
vertebrate UCP protein sequences and the reported conservation of
syntenic regions have demonstrated that there are orthologs of UCP1 in
mammals, amphibians, and ﬁsh [29,44–47]. The long branch leading to
eutherian UCP1 is indicative of strong structural divergence although the
observed amino acid changes are due to purifying rather than positive
selection (Fig. 2) [45,46]. Hence, it seems clear that structural divergence
was accompanied by a functional shift. It can be envisaged that ancestral
UCP1 probably had a role in protection against oxidative stress in tissues
where itwas expressed, and that the coexistenceof paralogs (UCP2and3)
that could fulﬁll its function, together with the restriction of UCP1 ex-
pression to BAT allowed the functional co-option to assume the thermo-
genic role in eutherians [29,46]. Indeed, the carp UCP1 does not have a
thermoregulatory function since its expression in the liver decreases
when ﬁsh are exposed to cold and, furthermore, its functional characteri-
zation has demonstrated that it does not display the distinctive nucleo-
tide-sensitive basal proton conductance found in the eutherianUCP1 [48].
3. Fatty acid uncoupling mediated by the mitochondrial carriers
As we have said earlier, the ability of FA to uncouplemitochondrial
respiration has been known for decades although only recently it has
been shown that the members of the mitochondrial carrier family
participate in the protonophoric cycle. These observations have been
made both with isolatedmitochondria from different sources and alsoin reconstituted systems. The prominent inhibitory effect of carbox-
yatractylate is probably due to the high abundance of the ANT in the
IMM. However, BAT mitochondria present a much higher sensitivity
to FA uncoupling and, in fact, the ﬁrst bioenergetic studies performed
with these mitochondria clearly established the need for the presence
of albumin in the respiration buffers to observe respiratory control
[42,49]. This high FA sensitivitywas subsequently linked to thepresence
of the uncoupling protein UCP1. These observations were later con-
ﬁrmed with the comparison of BAT mitochondria from cold-adapted
animals with those reared at thermoneutral temperature where the FA
effects correlated with the UCP1 content [50]. Subsequently, with the
development of systems for the recombinant expression of the UCPs in
yeasts, it has beenpossible todemonstrate thatwhenUCP1 is expressed,
Saccharomyces cerevisiae mitochondria display a FA sensitivity compa-
rable to those from BAT [51]. Finally, ablation of UCP1 in transgenic
animals results in a lower FA sensitivity [52]. Since this high afﬁnity is
not observed with mitochondria containing either UCP2 or UCP3,
several groups have generated protein chimeras made of domains from
the uncoupling proteins UCP1, UCP2 and UCP3 and demonstrated that
the hydrophilic loop that connects the transmembrane domains 3 and 4
confersUCP1 its high FA afﬁnity [53–55].Wehave long emphasized that
the high FA-afﬁnity of UCP1 correlateswith the physiological regulation
of its thermogenic activity. Under non-thermogenic conditions, purine
nucleotides maintain the protein inhibited and when noradrenaline
signals the initiation of thermogenesis, its binding to β3-receptors sets
off a lipolytic cascade. The FFA liberated serve two functions: they are
the substrates for respiration and activators of UCP1 [42,43]. Aswe have
already stated, the shift in the biochemical properties of this mito-
chondrial carrier ﬁts with the regulation of thermogenesis, and provide
evidence that eutherian UCP1 evolved to achieve its heat-generating
capacity in the physiological context provided by the brown adipocyte
[29]. The carrier-mediated FA-induced uncoupling has also been
suggested to play a role in thermoregulatory heat production [16,18]
and in the control of the generation of ROS [56].
A recentpublicationhas shown thatYarrowia lipolyticadoesnot have
orthologs of the known members of the UCP family but that the oxalo-
acetate carrier (OAC) presents an uncoupling activity stimulated by FA
and inhibited by purine nucleotides that resembles the activity and
regulation of UCP1 [57]. Y. lipolytica is an oleaginous yeast with a dy-
namic FA metabolism that stores large amounts of triglycerides in lipid
bodies [58]. In the exponential phase lipids are predominantly used to
build membranes, while in the stationary phase, FA are used as carbon
sources [59,60]. The FA activation of the OAC would be linked to the
decrease in ROS production and/or the reoxidation of NAD(P)H under
the conditions of low ATP demand of the stationary phase. We can
envisage that the OAC in Y. lipolytica evolved to allow an FA-induced
uncoupling activity while retaining the original transport activity [57].
This evolutionary adaptation would be linked to the peculiar metabo-
lismof this oleaginous yeast and, for example, S. cerevisiaemitochondria
show no evidence for the presence of a similar UCP-like activity [51,61]
despite the presence of an ortholog of the Yarrowia OAC.
4. Mechanism of fatty acid action
The members of the mitochondrial transporter superfamily are
mainly anion carriers. The experiments with BAT mitochondria in the
early seventies indicated that these mitochondria had an atypical
permeability to anions thatwas soon related to the nucleotide-sensitive
uncoupling pathway responsible for the thermogenic capacity of the
tissue [62–64]. However, the relationship between the anion perme-
ability, high FA sensitivity and the energy dissipation pathway (UCP1)
has been controversial. The fact that protons and anions share a com-
mon pathway has rarely been disputed due to the unequivocal demon-
stration of the competition between chloride and protons for the path
and their identical nucleotide sensitivity [43,62,63]. However, the puz-
zling observation of the lack of inﬂuence of albumin, i.e. low FA
Fig. 2. Phylogenetic relationships of the uncoupling protein family and the mitochondrial carriers with highest homology. 400 full-length, non-redundant protein sequences
corresponding to phosphate carriers (PIC); adenine nucleotide translocators (ANT); oxaloacetate carriers (OAC); dicarboxylate carriers (DIC); oxoglutarate carriers (OGC);
uncoupling proteins (UCP) and a set of carriers of yet undeﬁned function (UnkC) were retrieved fromNCBI and ENSEMBL public databases and aligned. Themaximum likelihood tree
was inferred using PhyML. Tree topology was drawn by using Dendroscope and the circular tree generated with FigTree. Other abbreviations: BMCP1, brain mitochondrial carrier
protein 1 (also termed UCP5); KMCP, kidney mitochondrial carrier protein; pUCP, plant uncoupling protein. The branch leading to the eutherian UCP1 and the position of the OAC
from Y. lipolytica are indicated. See reference [57] for further details.
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that FA were the physiological regulators of proton transport through
UCP1 were not easily reconciled. A hypothesis was put forward
suggesting the existence of two pathways inside the protein, one FA-
sensitive for protons and the other for anions such as chloride [63,64].
The latter demonstration that the reconstituted UCP1 could catalyze a
nucleotide-sensitive transport of a wider variety of anions and that the
transport rate increased with the anion hydrophobicity led to the
proposal that FA were UCP1 substrates [65]. By that time, the
involvement of the ANT in the uncoupling action of FA had been
demonstrated and thus a commonmechanism for the carrier-mediated
FA-uncoupling was proposed [18]. Themechanism, known as the “fatty
acid cycling hypothesis,”, proposed that UCP1, like the rest of
mitochondrial carriers, would catalyze the translocation of the anionic
form of the FA and once in the cytosolic side of the membrane, thecarboxylate groupwould pick up a proton and the protonated FAwould
ﬂip-ﬂopback to thematrix sidewhere theprotonwould be released and
the protonophoric cycle completed (Fig. 3a) [18].
The mechanism of activation of UCP1 has been studied in detail
over the years and the analysis of chemical nature of the compounds
that increase the proton conductance has provided valuable informa-
tion. The structural requirements for the activemolecules do not appear
to be very stringent, thus compoundswith a free carboxylate group and
with sufﬁcient lipid solubility will increase the proton conductance. A
secondpolar group cannot bepresentunless it is close to the carboxylate
[66,67]. The FA-cycling hypothesis imposes restrictions on the nature of
the active compounds since their protonated forms have to ﬂip-ﬂop
across the IMM. Thus it has been shown in liposomes that a bulky-planar
structure, like a benzene ring, at the end of the aliphatic tail hampers its
permeation across the membrane [68,69]. However, all-trans retinoic
Fig. 3.Mechanisms for the activation of the uncoupling protein UCP1 by fatty acids. Two hypotheses have been put forward to explain the mechanism of activation. (a) “Fatty acid
cycling hypothesis”: UCP1 translocates the FA anion from the matrix to the intermembrane side of the IMM to complete a protonophoric cycle that allows a net ﬂux of protons to the
matrix. (b) “Proton buffering model”: FA activate UCP1 overriding the nucleotide inhibition of the basal proton conductance. The carboxylate binds protons and delivers them to a
site from which they are translocated to the matrix side of the membrane.
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and, according to the liposome permeation data, they should not ﬂip-
ﬂop [67]. Alkylsulfonates constitute another interesting group of com-
pounds because of their resemblance to FA but with a pKa for the
sulfonic groupmuch lower than that of the carboxylate. The acid group
cannot be protonated at physiological pH and therefore alkylsulfonates
cannot act as a mobile proton carriers. Experiments in isolated mito-
chondria have demonstrated that long-chain alkylsulfonates do activate
UCP1 and therefore they have become a fundamental argument against
the “FA-cycling hypothesis” [20]. A subsequent paper questioned the
undecanosulfonate data arguing that their uncoupling effect was due to
the displacement of FA bound to albumin [70]. The displaced FA would
be responsible for the observed activation of UCP1. However, a close
scrutiny of the data presented reveals that, in the absence of albumin,
undecanosulfonate was indeed active. The apparent lower activity was
due to an increasedbasal proton conductancedue to the lackof albumin.
There is an alternative mechanism for the activation of UCP1 by FA
known as the “proton buffering model” that proposes that UCP1 is a
proton transporter and the carboxylate of the FA would be part of the
proton translocation pathway (Fig. 3b) [20,43,64].
The expression of the uncoupling protein UCP3 has been linked to
FA metabolism. Thus, situations that lead to an increase in plasma FA,
such as fasting or high-fat feeding, cause an increase in muscle UCP3
mRNA levels [71]. In the same direction points the experiments where
the overexpression of lipoprotein lipase [72] or the inhibition of
carnitine palmitoyl transferase-1 (CPT1) by etomoxir raises the intra-
cellular FA levels and also those of UCP3 [73]. Finally, the presence of a
PPARα response element in the UCP3 gene promoter also suggests
that UCP3 function could be related to FA metabolism [74]. Several
putative roles have been ascribed to UCP3 in FA handling. First, UCP3
could have a detoxiﬁcation role, removing lipid peroxides from the
matrix side of the IMM [75]. The idea is that since FA oxidation leads
to superoxide formation and this occurs mainly at the matrix side of
the IMM, matrix bound FA would be especially prone to lipid per-
oxidation. Highly reactive FA peroxides could accumulate in the IMM
and to avoid damage to the mtDNA, UCP3 would translocate the FA
peroxides to the outer face of the IMM. The charges present in the
aliphatic chain would prevent their return to the matrix side when
protonated. A second role would be to export FA to prevent their
accumulation in themitochondrial matrix when there is an increase in
FA supply [76]. This situation could be reached if, for example, certain
fatty acyl-CoAs were poorly oxidised by mitochondria. Acyl-CoA
thioesterases would release the CoA moiety and UCP3 could then
export the nonmetabolised FA. The samewould occur if FA supplywere
to exceed the oxidation rate aswhen CPT1 is inhibited by etomoxir [73].In this case, however, it is not clear how the FA return would be
prevented since the electrochemical proton gradient would cause the
protonation of the FA anion and would drive its ﬂip-ﬂop back to the
matrix side. Harper and co-workers have recently demonstrated that
muscle mitochondria fromwild-type and UCP3 knock-out mice equally
export palmitate and that UCP3 is not required for FA oxidation, thus
ruling out the hypothesis of a FA-translocating activity [77]. Their new
data point for a role of UCP3 in the protection against oxidative stress.
5. Concluding remarks
High FA levels have deleterious effects on cells and mitochondria is
one of their targets. The effects are mainly related to oxidative stress
although they can also affect the efﬁciency of the oxidative phosphory-
lation. Several mitochondrial carriers have been shown to mediate in the
uncoupling action of FA although the mechanism is not fully established.
It is worth mentioning that several members of the carrier family have
been shown to display the ability to switch from a carriermechanism to a
channel or pore mode [21,78]. Thus, it has been shown that under patch
clamp conditions the ANT, PIC and UCP1 display channel conductances
that range from the 25 pS in the PIC to 600 pS in the ANT. Modiﬁcation of
critical cysteine residues also alters the transport properties and, for
example, thiol reagents and oxidative stress modify sulfhydryl groups in
the ANT that lead to an increased probability of PTP opening [9]. FA also
induce the classical cyclosporin-sensitive permeability transition that
could be the result of two mechanisms that are non mutually exclusive
[3,79,80]. First, their uncoupling activity could cause membrane depolar-
ization and, second, their physical interaction with the ANT or PIC could
alter, for example, the voltage sensor and cause the shift to the poremode.
The end result would be PTP opening, OMM permeabilization, release of
apoptogenic factors and the initiation of apoptosis.
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